Regeneron Clinches Patent Victory Against Mylan Over Biosimilar – Bloomberg Law News

Mylan Pharmaceuticals Inc. is liable for infringing one of Regeneron Pharmaceutical Inc.’s patents for a protein antagonist used in Eylea, …